Voriconazole
Term · Oncology and biomedicine · MLC-T-ONC-009318
A drug that treats infections caused by fungi.
A synthetic triazole with antifungal activity. Voriconazole selectively inhibits 14-alpha-lanosterol demethylation in fungi, preventing the production of ergosterol, an essential constituent of the fungal cell membrane, and resulting in fungal cell lysis.
| Identifier | MLC-T-ONC-009318 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009318",
"term": "Voriconazole",
"field": "Oncology and biomedicine",
"definitions": [
"A drug that treats infections caused by fungi.",
"A synthetic triazole with antifungal activity. Voriconazole selectively inhibits 14-alpha-lanosterol demethylation in fungi, preventing the production of ergosterol, an essential constituent of the fungal cell membrane, and resulting in fungal cell lysis."
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/voriconazole/"
}
Record 17,339 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.